Jaime Bartushak
2017
In 2017, Jaime Bartushak earned a total compensation of $455.1K as Chief Financial Officer at Citius Pharmaceuticals, a 135% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $100,000 |
|---|---|
| Option Awards | $105,149 |
| Salary | $250,000 |
| Total | $455,149 |
Bartushak received $250K in salary, accounting for 55% of the total pay in 2017.
Bartushak also received $100K in non-equity incentive plan and $105.1K in option awards.
Rankings
In 2017, Jaime Bartushak's compensation ranked 12,176th out of 14,666 executives tracked by ExecPay. In other words, Bartushak earned more than 17.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,176 out of 14,666 | 17th |
Division Manufacturing | 4,795 out of 5,772 | 17th |
Major group Chemicals And Allied Products | 1,756 out of 2,075 | 15th |
Industry group Drugs | 1,456 out of 1,731 | 16th |
Industry Pharmaceutical Preparations | 1,128 out of 1,333 | 15th |
Source: SEC filing on December 13, 2017.
Bartushak's colleagues
We found two more compensation records of executives who worked with Jaime Bartushak at Citius Pharmaceuticals in 2017.
News
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018